President Joe Biden’s plan to incubate breakthrough biomedical discoveries in a new entity within the National Institutes of Health could lead to one of the largest shakeups to the medical research agency in at least a decade.
The proposed Advanced Research Projects Agency for Health would embrace the public-private partnership approach that was used to develop Covid-19 vaccines in record time. Potential project ideas include a single shot to protect against the top 10 infectious diseases and an mRNA vaccine to shield against common cancers.
The White House is driving the plans for the $6.5 billion agency. It’s gaining momentum ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.